Ditchcarbon
  • Contact
  1. Organizations
  2. Zai Lab
Public Profile
Pharmaceutical Preparation Manufacturing
CN
updated a month ago

Zai Lab

Company website

Zai Lab Limited, commonly referred to as Zai Lab, is a prominent biopharmaceutical company headquartered in China. Founded in 2014, the company has rapidly established itself as a leader in the development of innovative therapies, focusing primarily on oncology, autoimmune diseases, and infectious diseases. With a strong operational presence in both China and the United States, Zai Lab is committed to addressing unmet medical needs through its robust pipeline of novel drug candidates. The company’s core offerings include a range of proprietary and partnered products, distinguished by their unique mechanisms of action and potential to improve patient outcomes. Zai Lab has achieved significant milestones, including successful collaborations with global pharmaceutical leaders and the launch of several key therapies in the Chinese market. Recognised for its commitment to innovation, Zai Lab continues to strengthen its position in the competitive biopharmaceutical landscape.

DitchCarbon Score

How does Zai Lab's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

37

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

33

Industry Benchmark

Zai Lab's score of 37 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.

58%

Let us know if this data was useful to you

Zai Lab's reported carbon emissions

In 2023, Zai Lab reported total carbon emissions of approximately 70,321,000 kg CO2e. This figure includes 15,000 kg CO2e from Scope 1 emissions, 4,664,000 kg CO2e from Scope 2 emissions, and a significant 65,642,000 kg CO2e from Scope 3 emissions. Compared to 2022, where total emissions were about 74,436,000 kg CO2e, this marks a reduction of approximately 4,115,000 kg CO2e. Zai Lab's emissions data is sourced directly from Zai Lab Limited, with no cascaded data from a parent organization. The company has made commitments to reduce its carbon footprint, although specific reduction targets have not been established. Notably, previous near-term targets have been removed, indicating a shift in their climate strategy. The pharmaceutical and biotechnology sector, in which Zai Lab operates, is under increasing scrutiny for its environmental impact. As such, Zai Lab's commitment to addressing climate change is crucial for aligning with industry standards and expectations. The company has not yet committed to a net-zero target, but it continues to engage in climate initiatives.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

202120222023
Scope 1
28,400
00,000
00,000
Scope 2
3,536,600
0,000,000
0,000,000
Scope 3
-
00,000,000
00,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Zai Lab's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Zai Lab is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Zai Lab is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Adagene Inc.

CN
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Beigene

CN
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Merck And Co

US
•
Pharmaceutical Preparation Manufacturing
Updated about 8 hours ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

TG Therapeutics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Byondis B.V.

NL
•
Research and development services (73)
Updated about 1 month ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251023.16
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy